Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
iScience ; 26(11): 108136, 2023 Nov 17.
Article in English | MEDLINE | ID: mdl-37876823

ABSTRACT

Alterations of the microbiome are linked to increasingly common diseases such as obesity, allergy, and inflammatory bowel disease. Post-industrial lifestyles are thought to contribute to the gut microbiome alterations that cause or aggravate these diseases. Comparing communities across the industrialization spectrum can reveal associations between gut microbiome alterations and lifestyle and health, and help pinpoint which specific aspect of the post-industrial lifestyle is linked to microbiome alterations. Here, we compare the gut microbiomes of 60 mother and infant pairs from rural and urban areas of Senegal over two time points. We find that urban mothers, who were more frequently overweight, had different gut microbiome compositions than rural mothers, showing an expansion of Lachnospiraceae and Enterobacter. Urban infants, on the other hand, showed a delayed gut microbiome maturation and a higher susceptibility to infectious diseases. Thus, we identify new microbiome features associated with industrialization, whose association with disease may be further investigated.

2.
Int J Mol Sci ; 23(23)2022 Dec 06.
Article in English | MEDLINE | ID: mdl-36499731

ABSTRACT

Intestinal dysbiosis is a key feature in the pathogenesis of inflammatory bowel disease (IBD). Acyl-homoserine lactones (AHL) are bacterial quorum-sensing metabolites that may play a role in the changes in host cells-gut microbiota interaction observed during IBD. The objective of our study was to investigate the presence and expression of AHL synthases and receptor genes in the human gut ecosystem during IBD. We used an in silico approach, applied to the Inflammatory Bowel Disease Multi'omics Database comprising bacterial metagenomic and metatranscriptomic data from stools of patients with Crohn's disease (CD) (n = 50), ulcerative colitis (UC) (n = 27) and non-IBD controls (n = 26). No known putative AHL synthase gene was identified; however, several putative luxR receptors were observed. Regarding the expression of these receptor genes, the luxR gene from Bacteroides dorei was under-expressed in IBD patients (p = 0.02) compared to non-IBD patients, especially in CD patients (p = 0.02). In the dysbiosis situation, one luxR receptor gene from Bacteroides fragilis appeared to be over-expressed (p = 0.04) compared to that of non-dysbiotic patients. Targeting LuxR receptors of bacterial quorum sensing might represent a new approach to modulate the gut microbiota in IBD.


Subject(s)
Crohn Disease , Inflammatory Bowel Diseases , Humans , Acyl-Butyrolactones/metabolism , Ecosystem , Quorum Sensing/genetics , Dysbiosis , Inflammatory Bowel Diseases/metabolism
3.
Sci Rep ; 12(1): 9440, 2022 06 08.
Article in English | MEDLINE | ID: mdl-35676403

ABSTRACT

In the gut ecosystem, microorganisms regulate group behaviour and interplay with the host via a molecular system called quorum sensing (QS). The QS molecule 3-oxo-C12:2-HSL, first identified in human gut microbiota, exerts anti-inflammatory effects and could play a role in inflammatory bowel diseases where dysbiosis has been described. Our aim was to identify which signalling pathways are involved in this effect. We observed that 3-oxo-C12:2-HSL decreases expression of pro-inflammatory cytokines such as Interleukine-1ß (- 35%) and Tumor Necrosis Factor-α (TNFα) (- 40%) by stimulated immune RAW264.7 cells and decreased TNF secretion by stimulated PBMC in a dose-dependent manner, between 25 to 100 µM. Transcriptomic analysis of RAW264.7 cells exposed to 3-oxo-C12:2-HSL, in a pro-inflammatory context, highlighted JAK-STAT, NF-κB and TFN signalling pathways and we confirmed that 3-oxo-C12:2-HSL inhibited JAK1 and STAT1 phosphorylation. We also showed through a screening assay that 3-oxo-C12:2-HSL interacted with several human bitter taste receptors. Its anti-inflammatory effect involved TAS2R38 as shown by pharmacologic inhibition and led to an increase in intracellular calcium levels. We thus unravelled the involvement of several cellular pathways in the anti-inflammatory effects exerted by the QS molecule 3-oxo-C12:2-HSL.


Subject(s)
Gastrointestinal Microbiome , Quorum Sensing , 4-Butyrolactone/metabolism , Anti-Inflammatory Agents/metabolism , Ecosystem , Homoserine/metabolism , Humans , Leukocytes, Mononuclear/metabolism , Pseudomonas aeruginosa/physiology , Taste
4.
World J Gastroenterol ; 27(42): 7247-7270, 2021 Nov 14.
Article in English | MEDLINE | ID: mdl-34876787

ABSTRACT

Bacteria are known to communicate with each other and regulate their activities in social networks by secreting and sensing signaling molecules called autoinducers, a process known as quorum sensing (QS). This is a growing area of research in which we are expanding our understanding of how bacteria collectively modify their behavior but are also involved in the crosstalk between the host and gut microbiome. This is particularly relevant in the case of pathologies associated with dysbiosis or disorders of the intestinal ecosystem. This review will examine the different QS systems and the evidence for their presence in the intestinal ecosystem. We will also provide clues on the role of QS molecules that may exert, directly or indirectly through their bacterial gossip, an influence on intestinal epithelial barrier function, intestinal inflammation, and intestinal carcinogenesis. This review aims to provide evidence on the role of QS molecules in gut physiology and the potential shared by this new player. Better understanding the impact of intestinal bacterial social networks and ultimately developing new therapeutic strategies to control intestinal disorders remains a challenge that needs to be addressed in the future.


Subject(s)
Gastrointestinal Microbiome , Quorum Sensing , Bacteria , Dysbiosis , Ecosystem , Humans
5.
Int J Mol Sci ; 21(24)2020 Dec 11.
Article in English | MEDLINE | ID: mdl-33322538

ABSTRACT

BACKGROUND: Since acyl-homoserine lactone (AHL) profiling has been described in the gut of healthy subjects and patients with inflammatory bowel disease (IBD), the potential effects of these molecules on host cells have raised interest in the medical community. In particular, natural AHLs such as the 3-oxo-C12-HSL exhibit anti-inflammatory properties. Our study aimed at finding stable 3-oxo-C12-HSL-derived analogues with improved anti-inflammatory effects on epithelial and immune cells. METHODS: We first studied the stability and biological properties of the natural 3-oxo-C12-HSL on eukaryotic cells and a bacterial reporter strain. We then constructed and screened a library of 22 AHL-derived molecules. Anti-inflammatory effects were assessed by cytokine release in an epithelial cell model, Caco-2, and a murine macrophage cell line, RAW264.7, (respectively, IL-8 and IL-6) upon exposure to the molecule and after appropriate stimulation (respectively, TNF-α 50 ng/mL and IFN-γ 50 ng/mL, and LPS 10 ng/mL and IFN-γ 20 U/mL). RESULTS: We found two molecules of interest with amplified anti-inflammatory effects on mammalian cells without bacterial-activating properties in the reporter strain. The molecules furthermore showed improved stability in biological medium compared to the native 3-oxo-C12-HSL. CONCLUSIONS: We provide new bio-inspired AHL analogues with strong anti-inflammatory properties that will need further study from a therapeutic perspective.


Subject(s)
Acyl-Butyrolactones/therapeutic use , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/therapeutic use , Inflammatory Bowel Diseases/drug therapy , Acyl-Butyrolactones/chemistry , Analysis of Variance , Animals , Gastrointestinal Microbiome/drug effects , Inflammatory Bowel Diseases/microbiology , Mice , Pyrrolidinones/chemistry , RAW 264.7 Cells
6.
Tissue Barriers ; 8(4): 1832877, 2020 10 01.
Article in English | MEDLINE | ID: mdl-33100129

ABSTRACT

The intestine is home to the largest microbiota community of the human body and strictly regulates its barrier function. Tight junctions (TJ) are major actors of the intestinal barrier, which is impaired in inflammatory bowel disease (IBD), along with an unbalanced microbiota composition. With the aim to identify new actors involved in host-microbiota interplay in IBD, we studied N-acyl homoserine lactones (AHL), molecules of the bacterial quorum sensing, which also impact the host. We previously identified in the gut a new and prominent AHL, 3-oxo-C12:2, which is lost in IBD. We investigated how 3-oxo-C12:2 impacts the intestinal barrier function, in comparison to 3-oxo-C12, a structurally close AHL produced by the opportunistic pathogen P. aeruginosa. Using Caco-2/TC7 cells as a model of polarized enterocytes, we compared the effects on paracellular permeability and TJ integrity of these two AHL, separately or combined with pro-inflammatory cytokines, Interferon-γ and Tumor Necrosis Factor-α, known to disrupt the barrier function during IBD. While 3-oxo-C12 increased paracellular permeability and decreased occludin and tricellulin signal at bicellular and tricellular TJ, respectively, 3-oxo-C12:2 modified neither permeability nor TJ integrity. Whereas 3-oxo-C12 potentiated the hyperpermeability induced by cytokines, 3-oxo-C12:2 attenuated their deleterious effects on occludin and tricellulin, and maintained their interaction with their partner ZO-1. In addition, 3-oxo-C12:2 limited the cytokine-induced ubiquitination of occludin and tricellulin, suggesting that this AHL prevented their endocytosis. In conclusion, the role of 3-oxo-C12:2 in maintaining TJ integrity under inflammatory conditions identifies this new AHL as a potential beneficial actor of host-microbiota interactions in IBD.


Subject(s)
Acyl-Butyrolactones/metabolism , Cytokines/metabolism , Quorum Sensing/genetics , Tight Junctions/metabolism , Humans
7.
Front Immunol ; 11: 1827, 2020.
Article in English | MEDLINE | ID: mdl-32983093

ABSTRACT

Among numerous molecules found in the gut ecosystem, quorum sensing (QS) molecules represent an overlooked part that warrants highlighting. QS relies on the release of small molecules (auto-inducers) by bacteria that accumulate in the environment depending on bacterial cell density. These molecules not only are sensed by the microbial community but also interact with host cells and contribute to gut homeostasis. It therefore appears entirely appropriate to highlight the role of these molecules on the immune system in dysbiosis-associated inflammatory conditions where the bacterial populations are imbalanced. Here, we intent to focus on one of the most studied QS molecule family, namely, the type I auto-inducers represented by N-acyl-homoserine lactones (AHL). First described in pathogens such as Pseudomonas aeruginosa, these molecules have also been found in commensals and have been recently described within the complex microbial communities of the mammalian intestinal tract. In this mini-review, we will expound on this emergent field of research. We will first recall evidence on AHL structure, synthesis, receptors, and functions regarding interbacterial communication. Then, we will discuss their interactions with the host and particularly with agents of the innate and adaptive gut mucosa immunity. This will reveal how this new set of molecules, driven by microbial imbalance, can interact with inflammation pathways and could be a potential target in inflammatory bowel disease (IBD). The discovery of the general impact of these compounds on the detection of the bacterial quorum and on the dynamic and immune responses of eukaryotic cells opens up a new field of pathophysiology.


Subject(s)
4-Butyrolactone/analogs & derivatives , Acyl-Butyrolactones/metabolism , Bacteria/metabolism , Gastrointestinal Microbiome , Immunity, Mucosal , Intestinal Mucosa/metabolism , Intestinal Mucosa/microbiology , Quorum Sensing , 4-Butyrolactone/immunology , 4-Butyrolactone/metabolism , Acyl-Butyrolactones/immunology , Adaptive Immunity , Animals , Bacteria/growth & development , Bacteria/immunology , Host-Pathogen Interactions , Humans , Immunity, Innate , Intestinal Mucosa/immunology , Signal Transduction
8.
PLoS One ; 13(8): e0202587, 2018.
Article in English | MEDLINE | ID: mdl-30157234

ABSTRACT

BACKGROUND AND AIMS: N-acyl homoserine lactones (AHLs), which are autoinducer quorum-sensing molecules involved in the bacterial communication network, also interact with eukaryotic cells. Searching for these molecules in the context of inflammatory bowel disease (IBD) is appealing. The aims of our study were to look for AHL molecules in faecal samples from healthy subjects (HS) and IBD patients to correlate AHL profiles with the microbiome and investigate the effect of AHLs of interest on epithelial cells. METHODS: Using mass spectrometry, we characterised AHL profiles in faecal samples from HS (n = 26) and IBD patients in remission (n = 24) and in flare (n = 25) and correlated the presence of AHLs of interest with gut microbiota composition obtained by real-time qPCR and 16S sequencing. We synthesised AHLs of interest to test the inflammatory response after IL1ß stimulation and paracellular permeability on Caco-2 cells. RESULTS: We observed 14 different AHLs, among which one was prominent. This AHL corresponded to 3-oxo-C12:2 and was found significantly less frequently in IBD patients in flare (16%) and in remission (37.5%) versus HS (65.4%) (p = 0.001). The presence of 3-oxo-C12:2 was associated with significantly higher counts of Firmicutes, especially Faecalbacterium prausnitzii, and lower counts of Escherichia coli. In vitro, 3-oxo-C12:2 exerted an anti-inflammatory effect on Caco-2 cells. Interestingly, although 3-oxo-C12, the well-known AHL from Pseudomonas aeruginosa, increased paracellular permeability, 3-oxo-C12:2 did not. CONCLUSIONS: We identified AHLs in the human gut microbiota and discovered a new and prominent AHL, 3-oxo-C12:2, which correlates with normobiosis and exerts a protective effect on gut epithelial cells.


Subject(s)
Acyl-Butyrolactones/isolation & purification , Gastrointestinal Microbiome/genetics , Inflammatory Bowel Diseases/microbiology , Quorum Sensing/genetics , Acyl-Butyrolactones/chemistry , Acyl-Butyrolactones/metabolism , Caco-2 Cells , Cell Communication/genetics , Epithelial Cells/metabolism , Epithelial Cells/microbiology , Escherichia coli/genetics , Escherichia coli/isolation & purification , Escherichia coli/metabolism , Feces/microbiology , Gene Expression Regulation, Bacterial , Humans , Inflammatory Bowel Diseases/genetics , Inflammatory Bowel Diseases/metabolism , Pseudomonas aeruginosa/genetics , Pseudomonas aeruginosa/isolation & purification , Signal Transduction
9.
Rapid Commun Mass Spectrom ; 27(19): 2179-87, 2013 Oct 15.
Article in English | MEDLINE | ID: mdl-23996391

ABSTRACT

RATIONALE: Intestinal epithelial cells (IEC) secrete many chemokines in response to proinflammatory stimuli. We investigated their role in the mucosal inflammatory response in the intestine, by developing a non-targeted approach for analyzing the profile of peptides secreted by stimulated IEC, based on differential mass spectrometry analysis. METHODS: Lipopolysaccharide (LPS) was incubated with IEC as a proinflammatory stimulus. Differential peptidomic analysis was then carried out, comparing the profiles of IEC with and without LPS stimulation. A mass spectrometry procedure was developed, based on a liquid chromatography/tandem mass spectrometry (LC/MS/MS) approach without enzymatic pretreatment of the peptides. Partial de novo sequencing was carried out by Fourier transform ion cyclotron resonance (FTICR), and the native peptides in the culture media were identified. RESULTS: A major ion (m/z 7862.51) detected after stimulation was identified as GRO alpha and a minor ion (m/z 8918.17) was identified as IL-8. ELISA-based comparisons gave results consistent with those obtained by MS. Surprisingly, GRO alpha was secreted in amounts 5 to 15 times higher than those for IL-8 in our cellular model. The truncated form of IL-8, resulting from activation, was detected and distinguished from the native peptide by MS, whereas this was not possible with enzyme-linked immunosorbent assay (ELISA). CONCLUSIONS: Mass spectrometric analysis of culture media can be used to identify the principal peptides produced in response to the stimulation of IEC, and their metabolites. Mass spectrometry provides a comprehensive view of the chemokines and peptides potentially involved in gut inflammation, making it possible to identify the most appropriate peptides for further quantification.


Subject(s)
Chemokines/analysis , Chromatography, Liquid/methods , Epithelial Cells/metabolism , Intestinal Mucosa/metabolism , Tandem Mass Spectrometry/methods , Chemokine CXCL1/analysis , Chemokine CXCL1/chemistry , Chemokine CXCL1/metabolism , Chemokines/chemistry , Chemokines/metabolism , Dose-Response Relationship, Immunologic , Enzyme-Linked Immunosorbent Assay , Epithelial Cells/drug effects , HT29 Cells , Humans , Interleukin-8/analysis , Interleukin-8/chemistry , Interleukin-8/metabolism , Intestinal Mucosa/cytology , Lipopolysaccharides/pharmacology , Peptides/analysis , Peptides/chemistry , Peptides/metabolism , Proteome/drug effects
10.
Gut ; 62(4): 531-9, 2013 Apr.
Article in English | MEDLINE | ID: mdl-22993202

ABSTRACT

OBJECTIVE: Gut microbiota metabolises bile acids (BA). As dysbiosis has been reported in inflammatory bowel diseases (IBD), we aim to investigate the impact of IBD-associated dysbiosis on BA metabolism and its influence on the epithelial cell inflammation response. DESIGN: Faecal and serum BA rates, expressed as a proportion of total BA, were assessed by high-performance liquid chromatography tandem mass spectrometry in colonic IBD patients (42) and healthy subjects (29). The faecal microbiota composition was assessed by quantitative real-time PCR. Using BA profiles and microbiota composition, cluster formation between groups was generated by ranking models. The faecal BA profiles in germ-free and conventional mice were compared. Direct enzymatic activities of BA biotransformation were measured in faeces. The impact of BA on the inflammatory response was investigated in vitro using Caco-2 cells stimulated by IL-1ß. RESULTS: IBD-associated dysbiosis was characterised by a decrease in the ratio between Faecalibacterium prausntizii and Escherichia coli. Faecal-conjugated BA rates were significantly higher in active IBD, whereas, secondary BA rates were significantly lower. Interestingly, active IBD patients exhibited higher levels of faecal 3-OH-sulphated BA. The deconjugation, transformation and desulphation activities of the microbiota were impaired in IBD patients. In vitro, secondary BA exerted anti-inflammatory effects, but sulphation of secondary BAs abolished their anti-inflammatory properties. CONCLUSIONS: Impaired microbiota enzymatic activity observed in IBD-associated dysbiosis leads to modifications in the luminal BA pool composition. Altered BA transformation in the gut lumen can erase the anti-inflammatory effects of some BA species on gut epithelial cells and could participate in the chronic inflammation loop of IBD.


Subject(s)
Bile Acids and Salts/metabolism , Inflammatory Bowel Diseases/enzymology , Inflammatory Bowel Diseases/microbiology , Animals , Area Under Curve , Cell Line, Tumor , Chi-Square Distribution , Chromatography, High Pressure Liquid , Colonic Neoplasms/pathology , Enzyme-Linked Immunosorbent Assay , Feces/chemistry , Feces/microbiology , Humans , Metagenome , Mice , Real-Time Polymerase Chain Reaction , Statistics, Nonparametric , Tandem Mass Spectrometry
11.
Microbes Infect ; 14(3): 273-8, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22079149

ABSTRACT

Rotaviruses attach to intestinal cells in a process that requires glycan recognition. Some bacteria from the gut microflora have been shown to modify cell-surface glycans. In this study, human intestinal cultured cells were incubated with bacteria-derived soluble factors and infected with rotavirus. Results show that only bacterial soluble factors that increase cell-surface galactose namely, those of Bacteroides thetaiotaomicron and Lactobacillus casei were able to efficiently block rotavirus infections. Increasing cell-surface galactose using galactosyltransferase resulted in a similar blockage of rotavirus infections. These results indicate that manipulation of cell-surface intestinal glycans by bacterial soluble factors can prevent rotavirus infection in a species-specific manner, and should now be considered a potential therapeutic approach against rotavirus infection.


Subject(s)
Bacterial Proteins/pharmacology , Bacteroides/chemistry , Lacticaseibacillus casei/chemistry , Polysaccharides/chemistry , Rotavirus Infections/prevention & control , Rotavirus/drug effects , Bacterial Proteins/chemistry , Culture Media/chemistry , Galactose/chemistry , Galactosyltransferases/chemistry , HT29 Cells , Humans , Intestines/drug effects , Intestines/virology , Microbial Sensitivity Tests , Protein Binding , Rotavirus/pathogenicity , Rotavirus Infections/drug therapy , Solubility , Species Specificity , Spectrometry, Fluorescence/methods
12.
J Biomed Biotechnol ; 2010: 317545, 2010.
Article in English | MEDLINE | ID: mdl-20414353

ABSTRACT

The delivery of bioactive molecules directly to damaged tissues represents a technological challenge. We propose here a new system based on virus-like particles (VLP) from rotavirus, with a marked tropism for the gut to deliver bio-active molecules to intestinal cells. For this, nonreplicative VLP nanoparticles were constructed using a baculovirus expression system and used to deliver an exogenous biomolecule, the green fluorescent protein (GFP), into either MA104 cells or intestinal cells from healthy and 2,4,6-trinitrobenzene sulfonic acid (TNBS)-treated mice. Our results show that expression of rotavirus capsid proteins in baculovirus led to the auto assembly of VLP that display similar properties to rotavirus. In vitro experiments showed that VLP were able to enter into MA104 cells and deliver the reporter protein. Intragastric administration of fluorescent VLP in healthy and TNBS-treated mice resulted in the detection of GFP and viral proteins in intestinal samples. Our results demonstrate an efficient entry of non-replicative rotavirus VLP into the epithelial cell line MA104 and provide the first in vivo evidence of the potential of these nanoparticles as a promising safe candidate for drug delivery to intestinal cells.


Subject(s)
Drug Delivery Systems/methods , Nanoparticles/virology , Rotavirus/physiology , Virion/physiology , Virus Internalization , Analysis of Variance , Animals , Baculoviridae/genetics , Cell Line , Colitis/chemically induced , Disease Models, Animal , Enzyme-Linked Immunosorbent Assay , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Intestinal Mucosa/immunology , Intestinal Mucosa/virology , Male , Mice , Mice, Inbred BALB C , Spodoptera/metabolism , Trinitrobenzenesulfonic Acid , Virion/genetics
13.
FEMS Microbiol Lett ; 235(1): 65-72, 2004 Jun 01.
Article in English | MEDLINE | ID: mdl-15158263

ABSTRACT

Ursodeoxycholic acid-producing bacteria are of clinical and industrial interest due to the multiple beneficial effects of this bile acid on human health. This work reports the first isolation of 7-epimerizing bacteria from feces of a healthy volunteer, on the basis of their capacity to epimerize the primary bile acid, chenodeoxycholic acid, to ursodeoxycholic acid. Five isolates were found to be active starting from unconjugated chenodeoxycholic acid and its tauro-conjugated homologue, but none of these strains could epimerize the glyco-conjugated form. Biochemical testing and 16S ribosomal DNA sequencing converged to show that all five isolates were closely related to Clostridium baratii (99% sequence similarity), suggesting that this bacterial species could be responsible at least partially, for this bioconversion in the human gut.


Subject(s)
Chenodeoxycholic Acid/metabolism , Clostridium/metabolism , Feces/microbiology , Ursodeoxycholic Acid/metabolism , Aged , Chenodeoxycholic Acid/chemistry , Clostridium/isolation & purification , Humans , Isomerism , Male , Ursodeoxycholic Acid/chemistry
14.
Curr Microbiol ; 47(5): 425-30, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14669922

ABSTRACT

Some parameters of fermentation have been determined for Clostridium absonum in a chemostat by using a chemically defined medium with glucose as the sole source of carbon and energy. Steady-state continuous cultures were achieved at two dilution rates (D). Trends of the carbon flow were determined by comparison of ratios between the specific rates of formation of the three products of metabolism (lactate, acetate, butyrate). Chenodeoxycholate induced the 7alpha- and 7beta-hydroxysteroid dehydrogenases of C. absonum. In the presence of this inducer, the growth yield and the carbon recovery decreased, the carbon flow distribution was altered favoring acetate production, and a deficit in the reoxydation of nucleotidic cofactors was observed. In the presence of chenodeoxycholate, C. absonum would favor the production of energy at the expense of the reoxidation of nucleotidic cofactors so as to ensure its growth, and the epimerization of chenodeoxycholate to ursodeoxycholate.


Subject(s)
Chenodeoxycholic Acid/metabolism , Clostridium/metabolism , Ursodeoxycholic Acid/metabolism , Acetic Acid/metabolism , Butyrates/metabolism , Clostridium/growth & development , Coenzymes/metabolism , Culture Media/chemistry , Enzyme Induction , Glucose/metabolism , Hydroxysteroid Dehydrogenases/metabolism , Lactic Acid/metabolism , Oxidation-Reduction , Stereoisomerism
SELECTION OF CITATIONS
SEARCH DETAIL
...